Navigation Links
Soligenix to Host Conference Call and Webcast Discussion on Oral Mucositis
Date:10/28/2013

PRINCETON, N.J., Oct. 28, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that Christopher J. Schaber, PhD, President and Chief Executive Officer, Oreola Donini, PhD, Vice President of Preclinical Research and Development, and Stephen T. Sonis, DMD, DMSc, Clinical Professor of Oral Medicine at Harvard School of Dental Medicine, Senior Surgeon and Chief, Divisions of Oral Medicine at Brigham and Women's Hospital and the Dana-Farber Cancer Institute, and Chief Scientific Officer of Biomodels, LLC, as well as Scientific Advisory Board Member and Lead Advisor for the Soligenix Phase 2 clinical study of SGX942 for the treatment of oral mucositis in head and neck cancer, will participate in an expert call and webcast, entitled: Oral Mucositis – Advancing the Next Generation of Therapies.

The expert call and webcast will be on November 1, 2013 at 2:00 PM EDT in a moderated format. The analyst moderator for the call will be Jason Kolbert, Managing Director of Biotechnology Research at the Maxim Group. 

Dial-in for the conference call is 888-428-7458.  To access the live audio webcast of the discussion, please log on through the link: http://www.infiniteconferencing.com/join with passcode 13274022.  A replay of the webcast will be available one hour after the conclusion of the live event.

About SGX942
SGX942 is an innate defense regulator (IDR), a new class of short, synthetic peptides that has a novel mechanism of action in that it has simultaneous anti-inflammatory
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
2. Soligenix Reports Year-End 2012 Financial Results and Highlights Recent Accomplishments
3. Soligenix Announces Collaboration with Infectious Disease Research Institute to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants
4. Soligenix Reports Year-End 2011 Financial Results and Highlights Recent Accomplishments
5. Soligenix Announces 1 for 20 Reverse-Split of its Common Stock
6. Proove Biosciences Will Be Exhibiting At The 2013 Common Sense Pain Management Conference
7. Z Trim to Present at the 2013 Clean Label Conference
8. Vet-Stem, Inc. Founder and CEO Presents at TargetMeeting’s 3rd World Drug Discovery Online Conference
9. The Conference Forum Announces the Launch of the 2nd Annual Medicaid Rebate Summit
10. Techne Corporation To Host Conference Call On October 29, 2013 To Announce First Quarter Financial Results
11. Sigma-Aldrich Announces Q3 2013 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... DUBLIN , Aug. 27, 2014 ... the "Global Enzyme for Pulp & Paper Industry ... The Global Enzyme for Pulp & Paper Industry ... the current state of the global enzyme for pulp ... basic overview of the industry including definitions, classifications, applications ...
(Date:8/27/2014)... 27, 2014  ARCH Venture Partners, one of ... the development of seed and early-stage advanced technology ... closed with more than $400 million in subscriptions. ... subscription target by more than $150 million. ... strength and potential of our approach to finding ...
(Date:8/27/2014)... 2014 Riviera Beach, Florida based ... creation of the Sancilio Scientific Advisory Board (SSAB). ... philosophy of looking to nature for pharmaceutical advancements, ... are based on sound scientific data, analyses, expertise ... provides a vehicle for SCI to receive peer ...
(Date:8/27/2014)... After the boom of the energy ... beverage craze is going to be the stress relief ... use Stress Relief energy pattern which can be applied ... a beverage, including minerals, herbs and liquids. Stress Relief ... power into rapid recovery and helping to adapt more ...
Breaking Biology Technology:Global Enzyme for Pulp & Paper Industry Report 2014 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4
... step closer to creating a micro-aircraft that flies with the ... aerodynamic secrets of insect flight. Dr John Young, from ... and a team of animal flight researchers from Oxford University,s ... locusts in action in a wind tunnel, capturing how the ...
... , , SAN ... ("STI"), a privately-held and development-stage biopharmaceutical company with a ... human therapeutic antibodies for the treatment of a variety ... of QuikByte Software, Inc. (OTC Bulletin Board: QBSW), a ...
... , , , , ... independent, nonprofit research and development institute, announced today that John J. ... September 1, 2009. Young will become the SRI Board,s tenth ... the business community. , , "Throughout his career, ...
Cached Biology Technology:Secrets of insect flight revealed 2Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger 2Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger 3Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger 4John J. Young, Jr. Joins SRI Board of Directors 2John J. Young, Jr. Joins SRI Board of Directors 3
(Date:8/27/2014)... the Volunteer Wildfire Services of South Africa as "Cape ... residents in certain parts of the province on Monday ... high veld fire danger rating is expected in the ... Kei and Mnquma area. Strong winds often occurred ... bring lightning strikes and subsequent fire and the wind ...
(Date:8/27/2014)... number of consumers are willing to pay a premium ... whether they,re getting what the label claims is another ... devising a new way to make sure farms are ... ACS, Journal of Agricultural and Food Chemistry , ... the Bavarian Health and Food Safety Authority and the ...
(Date:8/27/2014)... of studies have shown that excessive iron ... Parkinson,s disease. Previous studies from Chunyan Guo ... China have shown that baicalin prevented iron ... metal transporter 1 expression, and increased ferroportin ... rotenone-induced Parkinson,s disease rats. However, the relationship ...
Breaking Biology News(10 mins):
... night blindness, an inherited condition that affects one,s ability to ... mutation in a calcium channel protein that shuttles calcium into ... University School of Medicine have teased apart the molecular mechanism ... cells control calcium levels. The discovery, published in the Feb. ...
... a serious toll on plants and animals alike. When cells ... and, without water as a medium, chemicals and enzymes inside ... named "resurrection fern" ( Polypodium polypodioides ), can survive extreme ... their water content. How do the cells in these desiccation-tolerant ...
... March 18, 2010. How did China and Australia develop ... Europe? A panel of U.S. experts will try to ... a workshop at the National Science Foundation (NSF) in Arlington, ... the National Science Foundation and other Federal agencies, the World ...
Cached Biology News:Understanding night blindness and calcium 2Bringing dehydrated plants 'back to life' 2Bringing dehydrated plants 'back to life' 3Workshop on R&D for rapid vaccine development and production in Asia/Australia 2
Conjugation services for Antibodies, Proteins, Oligos, Peptides, Beads, bioconjugation, antibody-oligonucleotide, LNA peptide, LNA protein, LNA antibody, HRP, Alkaline phosphatase, phycoerythrin, FIT...
SCP-1 (P-17)...
Immunogen: Purified native p24 from strain IIIB. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biotin d anti-mouse Tim-1...
Biology Products: